Results 191 to 200 of about 209,193 (336)

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma. [PDF]

Cancer Med, 2020
Wang ZM, Zhang SL, Yang H, Zhuang RY, Guo X, Tong HX, Zhang Y, Lu WQ, Zhou YH.   +8 more
europepmc   +1 more source

Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC

, 2000
Peter Vajkoczy, Michael D. Menger, Roland Goldbrunner, Shugang Ge, T. Annie T. Fong, Brigitte Vollmar, Lothar Schilling, Axel Ullrich, K. Peter Hirth, Jörg C. Tonn, Peter Schmiedek, Sandra A. Rempel   +11 more
openalex   +1 more source

Current Advances of Antibacterial Biomaterials for Bone Regeneration

Advanced Materials Interfaces, EarlyView.
Effective treatment of infectious bone defects requires not only robust bone regeneration, but also the elimination of bacterial infection. This review highlights current cutting‐edge concepts and innovations in synthetic bone repair biomaterials and antibacterial bone repair materials, aiming to promote clinical translation and inspire broader ...
Xueping Kong, Xue Zhang, Ying Wang, Ben Zhang   +3 more
wiley   +1 more source

Identification of a novel tumor angiogenesis inhibitor targeting Shh/Gli1 signaling pathway in Non-small cell lung cancer. [PDF]

Cell Death Dis, 2020
Lei X, Zhong Y, Huang L, Li S, Fu J, Zhang L, Zhang Y, Deng Q, Yu X.   +8 more
europepmc   +1 more source

Angiogenesis inhibitors and hypoxia [PDF]

Nature Medicine, 2003
Judah Folkman, John V. Heymach, Mark W. Kieran   +2 more
openaire   +2 more sources

Nanostructured 316L Stainless Steel Stent Surfaces Improve Corrosion Resistance, and Enhance Endothelization and Hemocompatibility

Advanced Materials Interfaces, EarlyView.
This study investigates the impact of nanostructured surface modification on corrosion resistance, HUVEC functions, and platelet interactions of 316L SS for cardiovascular stents. Nanostructured surfaces enhanced HUVEC proliferation, migration, and angiogenesis‐related gene expression while reducing platelet adhesion and hemolysis.
Yasar Kemal Erdogan, Pelin Mutlu, Batur Ercan   +2 more
wiley   +1 more source

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient

Frontiers in Pharmacology, 2017
Camillo Porta, Camillo Porta, Alessandra Ferrari, Anna M. Czarnecka, Cezary A. Szczylik   +4 more
doaj   +1 more source

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors. [PDF]

Cancer Res Treat
Kang YK, Ryu MH, Hong YS, Choi CM, Kim TW, Ryoo BY, Kim JE, Weis JR, Kingsford R, Park CH, Jang S, McGinn A, Werner TL, Sharma S.   +13 more
europepmc   +1 more source

CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo. [PDF]

Thorac Cancer, 2020
Zhang K, Wang L, Wei A, Jia X, Liu X.
europepmc   +1 more source

2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF₁₆₅‐mediated mammalian angiogenesis

, 2000
Klas Norrby
openalex   +2 more sources